Physician profile
John B Foster
NPI 1396920906
$16,620.01
in general payments reported to CMS, 2019-2025
25 companies · $2,203 in 2025
The $2,203 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,407 · 2020: $770 · 2021: $1,774 · 2022: $2,232 · 2023: $1,300 · 2024: $1,935 · 2025: $2,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,399 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,398.70 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $4,573.82 | 2019-2021 | |
| Alcon Vision LLC | $4,552.43 | 2019-2025 | Clareon, Clareon Panoptix Pro, Hydrus Microstent |
| Johnson & Johnson Surgical Vision, INC. | $1,817.66 | 2019-2025 | Tecnis Iol, Tecnis Iol, Veritas Vision System |
| Sight Sciences, INC. | $1,489.65 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ocular Therapeutix, INC. | $1,487.85 | 2019-2025 | Dextenza |
| Biotissue Holdings INC. | $500.58 | 2021-2025 | |
| Rxsight INC | $488.85 | 2021-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Glaukos Corporation | $335.81 | 2019-2025 | |
| Allergan, INC. | $283.23 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $206.33 | 2024-2025 | Xdemvy |
| Abbvie INC. | $190.65 | 2022-2025 | |
| Nutech Spine, INC. | $138.67 | 2021 | |
| Novartis Pharmaceuticals Corporation | $130.17 | 2019-2023 | |
| Dompe US, INC. | $81.03 | 2020-2024 | Oxervate |
| Bausch & Lomb Americas INC. | $65.51 | 2022-2023 | Envista Mx60 Iol |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $62.47 | 2021 | |
| Rayner Intraocular Lenses Limited | $50.12 | 2022-2024 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Oyster Point Pharma, INC. | $35.71 | 2022-2024 | Ryzumvi, Tyrvaya |
| Aerie Pharmaceuticals, INC. | $21.81 | 2021 | |
| Harrow Eye, LLC | $20.80 | 2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $20.64 | 2022 | |
| Ivantis, INC | $18.92 | 2019 | |
| Lensar, INC. | $17.60 | 2025 | Lensar Laser System |
| Erbe USA INC | $15.00 | 2024 | |
| New World Medical,INC. | $14.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.